Stephenson Cancer Center Awarded $10.8 Million Grant to Expand Clinical Trials

Published: Wednesday, August 28, 2019 By: Staff Reports Source: Stephenson Cancer Center

The Stephenson Cancer Center at OU Medicine announced that it has been awarded a $10.8 million grant from the National Cancer Institute to expand its nationally recognized clinical trials program.

The co-principal investigators for the grant are Kathleen Moore, M.D., Virginia Kerley Cade Endowed Chair in Cancer Developmental Therapeutics and Associate Director for Clinical Research at the Stephenson Cancer Center, and Joan Walker, M.D., Louise and Clay Bennett Endowed Chair in Cancer and Professor and Chief, Section of Gynecologic Oncology, at the OU College of Medicine. 

For the past two years, the Stephenson Cancer Center has ranked No. 1 among all cancer centers in the nation for the number of patients participating in clinical trials sponsored through the NCI’s National Clinical Trials Network. That distinction stands not only for the past two years, but for the last five years cumulatively. In addition, the Stephenson Cancer Center has been a top three site nationally for the number of patients participating in NCI-sponsored precision medicine trials. 

ROBERT MANNEL, M.D., DIRECTOR OF THE STEPHENSON CANCER CENTER, ATTRIBUTED THE CENTER’S SUCCESS IN CLINICAL RESEARCH TO PHYSICIAN AND STAFF COMMITMENT TO EACH PATIENT WHO RECEIVES CARE AT THE CANCER CENTER.

“The mission of the Stephenson Cancer Center is to improve patient outcomes and reduce the burden of cancer for all Oklahomans,” he said. “One of the most important ways we do that is by offering a large portfolio of early- and late-phase clinical trials for all types and stages of cancer. This provides our patients access to the newest and most promising treatment, screening and diagnosis options.”

 With this multi-million dollar NCI grant, the Stephenson Cancer Center continues its status as a Lead Academic Participating Site in the National Clinical Trials Network, which was established by the NCI in 2014. Comprised of 30 of the top cancer centers in the nation, the National Clinical Trials Network is the largest clinical trials infrastructure in the nation for establishing new standards of cancer care and setting the stage for the approval of new therapies by the Food and Drug Administration.

The new six-year NCI grant will allow the Stephenson Cancer Center to continue to expand its robust clinical trials portfolio and infrastructure. Specifically, it will support the addition of new clinical research staff with expertise in research nursing, study coordination, regulatory affairs and data management.

“This new grant also supports NCI clinical trial staff and other infrastructure at Oklahoma Cancer Specialists and Research Institute (OCSRI) in Tulsa,” Mannel explained. “Through its affiliate relationship with OCSRI,

Back to top